A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS

P Sandercock, E Berge, M Dennis, J Forbes, P Hand, J Kwan, S Lewis, R Lindley, A Neilson, B Thomas, J Wardlaw

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-112
Number of pages112
JournalHealth Technology Assessment
Issue number26
Publication statusPublished - 2002

Keywords / Materials (for Non-textual outputs)

  • Brain Ischemia
  • Cost-Benefit Analysis
  • Diffusion of Innovation
  • Great Britain
  • Humans
  • Neuroprotective Agents
  • State Medicine
  • Stroke
  • Thrombolytic Therapy
  • Treatment Outcome

Cite this